Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Hanekamp

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Hematology|March 31, 2017
Leukemic stem cells: identification and clinical applicationDiana Hanekamp, Jacqueline Cloos, Gerrit Jan Schuurhuis
Pathology|December 30, 2019
Re: Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypesDiana Hanekamp, Costa Bachas, Arjan van de Loosdrecht, et al.
Cancers|November 13, 2021
Molecular Minimal Residual Disease Detection in Acute Myeloid LeukemiaChristian M Vonk, Adil S A Al Hinai, Diana Hanekamp, et al.
Cancers|June 2, 2021
AML/Normal Progenitor Balance Instead of Total Tumor Load (MRD) Accounts for Prognostic Impact of Flowcytometric Residual Disease in AMLDiana Hanekamp, Jesse M Tettero, Gert J Ossenkoppele, et al.
CNS Oncology|July 24, 2014
Targeting core (mutated) pathways of high-grade gliomas: challenges of intrinsic resistance and drug effluxFan Lin, Mark C de Gooijer, Diana Hanekamp, et al.
Blood|November 10, 2020
Early assessment of clofarabine effectiveness based on measurable residual disease, including AML stem cellsDiana Hanekamp, Lok Lam Ngai, Jeroen J W M Janssen, et al.
British Journal of Haematology|January 28, 2016
CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemiaBas Kersten, Matthijs Valkering, Rolf Wouters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2016
PI3K-mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse ModelsFan Lin, Mark C de Gooijer, Diana Hanekamp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 20, 2017
Diet-Derived Short Chain Fatty Acids Stimulate Intestinal Epithelial Cells To Induce Mucosal Tolerogenic Dendritic CellsGera Goverse, Rosalie Molenaar, Laurence Macia, et al.
Leukemia|February 15, 2023
Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progressionMargot F van Spronsen, Diana Hanekamp, Theresia M Westers, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Hematology|March 31, 2017
Leukemic stem cells: identification and clinical applicationDiana Hanekamp, Jacqueline Cloos, Gerrit Jan Schuurhuis
Pathology|December 30, 2019
Re: Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypesDiana Hanekamp, Costa Bachas, Arjan van de Loosdrecht, et al.
Cancers|November 13, 2021
Molecular Minimal Residual Disease Detection in Acute Myeloid LeukemiaChristian M Vonk, Adil S A Al Hinai, Diana Hanekamp, et al.
Cancers|June 2, 2021
AML/Normal Progenitor Balance Instead of Total Tumor Load (MRD) Accounts for Prognostic Impact of Flowcytometric Residual Disease in AMLDiana Hanekamp, Jesse M Tettero, Gert J Ossenkoppele, et al.
CNS Oncology|July 24, 2014
Targeting core (mutated) pathways of high-grade gliomas: challenges of intrinsic resistance and drug effluxFan Lin, Mark C de Gooijer, Diana Hanekamp, et al.
Blood|November 10, 2020
Early assessment of clofarabine effectiveness based on measurable residual disease, including AML stem cellsDiana Hanekamp, Lok Lam Ngai, Jeroen J W M Janssen, et al.
British Journal of Haematology|January 28, 2016
CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemiaBas Kersten, Matthijs Valkering, Rolf Wouters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2016
PI3K-mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse ModelsFan Lin, Mark C de Gooijer, Diana Hanekamp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 20, 2017
Diet-Derived Short Chain Fatty Acids Stimulate Intestinal Epithelial Cells To Induce Mucosal Tolerogenic Dendritic CellsGera Goverse, Rosalie Molenaar, Laurence Macia, et al.
Leukemia|February 15, 2023
Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progressionMargot F van Spronsen, Diana Hanekamp, Theresia M Westers, et al.
Pageof 3